STAAR urges stockholders to vote FOR Alcon merger at $28/sh, citing 59% VWAP premium

STAAR SURGICAL CO

Alcon merger offers $28.00 per share cash; 51% premium to Aug 4 close, 59% to 90-day VWAP.
Second-largest active holder Soleus Capital (≈6% stake) supports merger and intends to vote FOR.
45-day window shop expired Sep 19; no competing acquisition proposals were received.
Board warns standalone stock would fall from $18.49 pre-announcement amid declining China sales and competition.
Broadwood's claims called flawed; STAAR ranks last in 2024-2027E net sales CAGR vs peer set.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.